| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity-attenuated serum albumin-fused interleukin-33 suppresses experimental autoimmune encephalomyelitis
|
Budina, Erica
|
|
|
6 |
7 |
p.
|
artikel
|
| 2 |
A deep learning system for detecting systemic lupus erythematosus from retinal images
|
Li, Tingyao
|
|
|
6 |
7 |
p.
|
artikel
|
| 3 |
AI-enabled molecular phenotyping and prognostic predictions in lung cancer through multimodal clinical information integration
|
Lu, Yuxing
|
|
|
6 |
7 |
p.
|
artikel
|
| 4 |
A Rac-specific competitive inhibitor of guanine nucleotide binding reduces metastasis in triple-negative breast cancer
|
Dilasser, Florian
|
|
|
6 |
7 |
p.
|
artikel
|
| 5 |
Augment proteasome inhibitor efficacy activates CD8+ T cell-mediated antitumor immunity in breast cancer
|
Tang, Dongyang
|
|
|
6 |
7 |
p.
|
artikel
|
| 6 |
Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in vivo CAR-T therapy for inflamm-aging
|
Zhang, Zihan
|
|
|
6 |
7 |
p.
|
artikel
|
| 7 |
Ce6 derivative photodynamic therapy triggers PANoptosis and enhances antitumor immunity with LAG3 blockade in cutaneous squamous cell carcinoma
|
Chen, Diyan
|
|
|
6 |
7 |
p.
|
artikel
|
| 8 |
CLDN4 palmitoylation promotes hepatic-to-biliary lineage transition and lenvatinib resistance in hepatocellular carcinoma
|
Xu, Minghao
|
|
|
6 |
7 |
p.
|
artikel
|
| 9 |
Combined inhibition of KAT6A/B and Menin reverses estrogen receptor-driven gene expression programs in breast cancer
|
Olsen, Sarah Naomi
|
|
|
6 |
7 |
p.
|
artikel
|
| 10 |
Combined pharmacological targeting of CD9+ progenitors alleviates obesity-induced adipose tissue fibrosis and metabolic impairment
|
Rebière, Clémentine
|
|
|
6 |
7 |
p.
|
artikel
|
| 11 |
Comprehensive genetic profiling of sensorineural hearing loss using an integrative diagnostic approach
|
Lee, Sang-Yeon
|
|
|
6 |
7 |
p.
|
artikel
|
| 12 |
EGFR TKIs suppress MUC1 glycosylation through the PI3K/AKT/SP1/C1GALT1 pathway to enhance TnMUC1 CAR-T efficacy in EGFR-mutant NSCLC
|
Zhou, Ziwei
|
|
|
6 |
7 |
p.
|
artikel
|
| 13 |
Elucidating the heterogeneity of prediabetes through subphenotyping with a two-dimensional tree structure
|
Lin, Hong
|
|
|
6 |
7 |
p.
|
artikel
|
| 14 |
Endoscopic healing in pediatric IBD perpetuates a persistent signature defined by Th17 cells with molecular and microbial drivers of disease
|
Siebert, Kolja
|
|
|
6 |
7 |
p.
|
artikel
|
| 15 |
Enhancing 3D dopamine transporter imaging as a biomarker for Parkinson’s disease via self-supervised learning with diffusion models
|
Won, Jongjun
|
|
|
6 |
7 |
p.
|
artikel
|
| 16 |
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer
|
Severson, Tesa M.
|
|
|
6 |
7 |
p.
|
artikel
|
| 17 |
Extracellular vesicle heterogeneity through the lens of multiomics
|
Silva, Taylon F.
|
|
|
6 |
7 |
p.
|
artikel
|
| 18 |
Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platform
|
Zhang, Yuqing
|
|
|
6 |
7 |
p.
|
artikel
|
| 19 |
Immunogenicity of autologous and allogeneic human primary cholangiocyte organoid cellular therapies
|
Petrus-Reurer, Sandra
|
|
|
6 |
7 |
p.
|
artikel
|
| 20 |
Impact of the tumor immune contexture in microsatellite-stable metastatic colorectal cancer treated with avelumab, cetuximab, and irinotecan
|
Huyghe, Nicolas
|
|
|
6 |
7 |
p.
|
artikel
|
| 21 |
Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma
|
Liu, Shang-Xin
|
|
|
6 |
7 |
p.
|
artikel
|
| 22 |
Intrinsic chicory root fibers modulate colonic microbial butyrate-producing pathways and improve insulin sensitivity in individuals with obesity
|
Omary, Lina
|
|
|
6 |
7 |
p.
|
artikel
|
| 23 |
iPSC-derived trimodal T cells engineered with CAR, TCR, and hnCD16 modalities can overcome antigen escape in heterogeneous tumors
|
Yang, Bi-Huei
|
|
|
6 |
7 |
p.
|
artikel
|
| 24 |
Metabolic fingerprinting enables rapid, label-free histopathology in gastric cancer diagnosis and prognostic prediction
|
Teng, Fei
|
|
|
6 |
7 |
p.
|
artikel
|
| 25 |
MET pathway inhibition increases chemo-immunotherapy efficacy in small cell lung cancer
|
del Rey-Vergara, Raúl
|
|
|
6 |
7 |
p.
|
artikel
|
| 26 |
Moving cellular therapies to the front line for Ph+ B cell acute lymphoblastic leukemia
|
Feng, Yanzhi
|
|
|
6 |
7 |
p.
|
artikel
|
| 27 |
Neoadjuvant anlotinib/sintilimab plus chemotherapy in triple-negative breast cancer (NeoSACT): Phase 2 trial
|
Zhang, Liulu
|
|
|
6 |
7 |
p.
|
artikel
|
| 28 |
Neutralization of acyl coenzyme A binding protein for the experimental prevention and treatment of hepatocellular carcinoma
|
Li, Sijing
|
|
|
6 |
7 |
p.
|
artikel
|
| 29 |
Overcoming multidrug resistance in gastrointestinal cancers with a CDH17-targeted ADC conjugated to a DNA topoisomerase inhibitor
|
Wang, Rui
|
|
|
6 |
7 |
p.
|
artikel
|
| 30 |
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants
|
Revach, Or-Yam
|
|
|
6 |
7 |
p.
|
artikel
|
| 31 |
Perioperative administration of CBM588 in colorectal cancer radical surgery: A single-center, randomized controlled trial
|
Yang, Yongzhi
|
|
|
6 |
7 |
p.
|
artikel
|
| 32 |
RANKL/PD-1 dual blockade demonstrates survival benefit for patients with advanced lung adenocarcinoma harboring KRAS mutations
|
Li, Hong-Shuai
|
|
|
6 |
7 |
p.
|
artikel
|
| 33 |
Targeting synthetic lethality between non-homologous end joining and radiation in very-high-risk medulloblastoma
|
DeCarlo, Alexandria
|
|
|
6 |
7 |
p.
|
artikel
|
| 34 |
Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas
|
Labiano, Sara
|
|
|
6 |
7 |
p.
|
artikel
|
| 35 |
The expanding benefits of GLP-1 medicines
|
Gonzalez-Rellan, Maria J.
|
|
|
6 |
7 |
p.
|
artikel
|
| 36 |
UCPVax, a CD4 helper peptide vaccine, induces polyfunctional Th1 cells, antibody response, and epitope spreading to improve antitumor immunity
|
Laheurte, Caroline
|
|
|
6 |
7 |
p.
|
artikel
|
| 37 |
Unlocking the therapeutic potential of rigosertib as a selective therapy for ovarian cancer
|
Nath, Shalini
|
|
|
6 |
7 |
p.
|
artikel
|
Tijdschrift beschrijving